X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
John O'Quinn of Kirkland & Ellis. Courtesy photo John O’Quinn of Kirkland & Ellis. Courtesy photo

Our Litigator of the Week this week is John O’Quinn of Kirkland & Ellis. On Tuesday, O’Quinn secured a preliminary injunction for Eli Lilly barring the U.S. Department of Health & Human Services from implementing a new “administrative dispute resolution” procedure to decide disputes between pharmaceutical companies and so-called “covered entities” under the 340B Drug Pricing Program.

The 340B program has been the source of considerable controversy of late. The program forces drug makers to offer steep discounts to certain health care providers that serve low-income, at-risk patients, in order to participate in Medicare and Medicaid. Pharmaceutical companies, however, contend that for-profit pharmacies have acted as middlemen in the program and pocketed billions in discounts meant for low-income consumers.

This premium content is locked for
Litigation Daily subscribers only.

Already have an account?
Interested in customizing your subscription with Law.com access?
Contact our Sales Professionals at 1-855-808-4530 or send an email
to [email protected] to learn more.

Ross Todd

Ross Todd is the Editor/columnist for the Am Law Litigation Daily. He writes about litigation of all sorts. Previously, Ross was the Bureau Chief of The Recorder, ALM's California affiliate. Contact Ross at [email protected] On Twitter: @Ross_Todd.

More from this author

Law Firms Mentioned

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

On Trial: Lessons from a lifetime in the courtroomBook

Written by a distinguished N.Y. trial attorney, it distills the author's forty years of courtroom experience into a highly readable trove of wisdom and common-sense advic...

Get More Information
 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.